Momentum Stocks

Histogenics Says Phase 3 Trial of NeoCart Failed to Meet Primary Endpoint

Histogenics Says Phase 3 Trial of NeoCart Failed to Meet Primary Endpoint

Shares of Histogenics (HSGX), a clinical-stage company focused on the development of restorative cell therapies, fell nearly 64% in pre-market trading Wednesday after the company said its phase 3 trial of NeoCart failed to meet the primary endpoint of a statistically significant improvement in pain and function in a dual threshold responder analysis one year after treatment as compared to […]

Coupa Software Surges as Second Quarter Profit Surprises Investors

Coupa Software Surges as Second Quarter Profit Surprises Investors

Shares in Coupa Software (COUP) traded sharply higher early Wednesday after the company surprised investors by swinging to a profit in its fiscal second quarter, and as earnings and sales forecasts for the third quarter beat analysts’ estimates. Underpinned by strong growth in subscription revenues, group turnover surged by 38% to $61.7 million during the three months that ended July […]

Helios and Matheson Crumbles To Record Low on Q2 Loss

Shares of Helios and Matheson Analytics (HMNY), the parent company of MoviePass, fell to a new all-time low of $0.03 in early Wednesday trading following the release of disappointing Q2 results in which the company said it has “substantial doubt” it can continue as a going concern. “Without raising additional capital, there is substantial doubt about the Company’s ability to […]

Tribune Media May Review Assets, Make Acquisitions in Wake of Sinclair Deal Failure

Tribune Media (TRCO) could still explore a strategic review of some of its assets and start making acquisitions soon after killing its attempt to merge with Sinclair Broadcast Group (SBGI), S&P Global Ratings said on Wednesday. The agency raised its outlook on the Chicago-based broadcast and digital content company to stable from negative, while affirming its BB- issuer credit rating […]

CURO Group Holdings’ Price Target From Janney Boosted to $36 From $33

CURO Group Holdings’ Price Target From Janney Boosted to $36 From $33

CURO Group Holdings (CURO) received an increase to its price target Tuesday from Janney Montgomery Scott following the short-term credit provider’s late-Monday pricing of $690 million in senior secured notes, upsized from its previous plan to offer $675 million of the notes. Janney’s new price target on the stock is $36 per share, up from $33. This brings the target […]

Nasdaq Set For Eighth Straight Gain, Dow Lags on Soft Industrial and Energy Shares

Nasdaq Set For Eighth Straight Gain, Dow Lags on Soft Industrial and Energy Shares

Weighed down by losses in industrial and energy shares, the Dow Jones Industrial Average is lower for a second day, lagging modest gains in the other major averages. The Nasdaq is again outperforming its peers as gains in most of the FAANG stocks offsets losses in the semiconductor sector. Wall Street continued to ignore the simmering trade dispute between the […]

Viacom Reports Mixed Results as Advertising Dips, Paramount Pictures Gains

Viacom Reports Mixed Results as Advertising Dips, Paramount Pictures Gains

Viacom (VIA, VIAB) reported downbeat revenue for the fiscal third quarter as advertising revenue decreased, but earnings came in better than expected, and the entertainment company cheered growing profitability in its Paramount Pictures division. Revenue fell 4% to $3.24 billion, missing the consensus on Capital IQ for $3.27 billion. Adjusted diluted earnings rose by a penny to $1.18 a share, […]

Tesla Stock Surges as Musk Says May Take Company Private

Tesla Stock Surges as Musk Says May Take Company Private

Tesla (TSLA) shares jumped on Tuesday after co-founder Elon Musk tweeted that he was considering taking the electric-vehicle maker private. “Am considering taking Tesla private at $420. Funding secured,” the company’s chief executive officer said from his Twitter account. The shares were recently trading at $360.99. Musk, who often engages with both supporters and detractors on social media, didn’t offer […]

Cardinal Health’s Price Target From RBC Cut to $56 From $61

Cardinal Health’s Price Target From RBC Cut to $56 From $61

Cardinal Health (CAH) received a price-target reduction from RBC Capital Markets after the health-care services and products company reported fiscal Q4 results above analysts’ expectations Monday but the midpoint of its guidance range for fiscal 2019 adjusted earnings per share missed analysts’ mean estimate. The new price target from RBC is $56 per share, down from $61. The stock closed […]